[ARWR] YoY Quarter Result on 31-Dec-2017 [#Q1]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
09-Feb-2018
Financial Year
2018
Quarter
31-Dec-2017 [#Q1]
Profit Trend
QoQ- -22.99%
YoY- -9.21%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 21,303 29,455 34,658 3,510 4,365 44 171 123.31%
PBT -20,732 -2,674 12,037 -13,199 -12,086 -19,264 -22,575 -1.40%
Tax -2,169 1 -0 -614 -1,509 -77 -2,593 -2.92%
NP -20,732 -2,674 12,037 -13,199 -12,086 -19,264 -22,575 -1.40%
Tax Rate - - 0.00% - - - - -
Total Cost 42,035 32,128 22,621 16,709 16,452 19,308 22,746 10.76%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -97.32 -9.08 34.73 -376.06 -276.86 -44,032.95 -13,221.25 -55.86%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.20 -0.03 0.13 -0.18 -0.17 -0.32 -0.41 -11.26%
EPS Diluted -0.20 -0.03 0.13 -0.18 -0.17 -0.32 -0.41 -11.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.